Concept and Aims Cardiovascular diseases, including myocardial infarction (MI), are the leading cause of pre-mature death worldwide, constituting a major socio-economic burden on the European and glob

Activities The research work in TECHNOBEAT is divided into 9 work packages (WPs) with a specific partner dedicated to lead respective WPs which reflects that partners’ area of expertise. Within TECHNO

Energy Harvesting from Muscle Contractions Using Stretchable Nanocomposite Piezofibers Prof. Dr. A. Ruhparwar | Prof. Dr. J. Foroughi Wearable and Implantable Medical Devices (WIMDs) are revolutionizi

A Novel Concept of Ventricular Assist Devices (VADs) Prof. Dr. A. Ruhparwar | Prof. Dr. J. Foroughi Among the remarkable applications of smart materials in healthcare, artificial muscles epitomize inn

TECHNOBEAT Tools and Techno logies for B reakthrough in H ea rt Therapies- in short TECHNOBEAT is part of the Horizon 2020 funding programme of the European Commission. TECHNOBEAT is rooted in the ext

Consortium structure and expertise The TECHNOBEAT consortium is particularly well-equipped to significantly impact on the enormous challenges ahead in hiPSC-based cell therapies, as it gathers a uniqu

Programme Conference booklet NOW ONLINE! (PDF for download) Click here for topic titles and full list of speakers

Transplantationsmöglichkeiten im Zeitalter des Organmangels und Epidemiologie und Pathogenese primärer und sekundärer glomerulärer Erkrankungen Arbeitsgruppenleitung PD. Dr. med. Christos Chatzikyrkou

Disease Modeling Research Group Our research group is committed to identifying the genetic causes and developing potential cures for genetic disorders. We apply cutting edge sequencing technologies to